[1]
Phadungvorasart, W. and Kulkantrakorn, K. 2023. Janus kinase 1/2 inhibition with Baricitinib for treatment of anti-signal recognition particle necrotizing autoimmune myositis: a case report. The Bangkok Medical Journal. 19, 2 (Sep. 2023), 121. DOI:https://doi.org/10.31524/bkkmedj.2023.22.002.